Drawing for INVICTUS NUTRACEUTICALS

USPTO serial 79307472

INVICTUS NUTRACEUTICALS

Reviewed by CopyMark Law Group

Reg. 6908891Status 700Registered
Filing date
Status date
Registration date
Nov 29, 2022
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INVICTUS NUTRACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay J. Hulley

Lindsay J. Hulley Rutan & Tucker, LLP18575 Jamboree Road9th FloorIrvine, CA 92612

Goods and services

ClassDescriptionStatusFirst use
005Dietary food supplements; dietary nutritional supplements; dietary protein supplements; dietary supplements; dietary supplement drinks for energy; food supplements in the nature of dietary supplements; herbal dietary supplements; plant compounds for use as dietary supplements for medicinal purposes; plant extracts in the nature of dietary supplements; protein dietary supplements; dietetic food supplements adapted for medical purposes; food supplements for medical purposes; medicated food supplements; medicated preparations being food supplements; medicated supplements for foodstuffs for humans; medicated supplements for foodstuffs for human consumption; medicinal food supplements; nutritional supplements; nutritional supplements for medical use; protein supplements for humans; nutritional supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; vitamin supplements; vitamin supplements for foodstuffs for human consumption; preparations of vitamins; stimulants made of vitamins for improving exercise performance; dietary supplemental drinks in the nature of vitamin drinks; vitamin preparations; vitamin preparations for human consumption; vitamin preparations in tablet form; vitamin tablets; vitamins; capsules sold empty for medicines; medicines for muscle injuries and disorders, sports related injuries, improving exercise endurance, capacity and performance, increasing antioxidant levels, maintaining cholesterol and improving cardiovascular health, for human purposes; medicines for human use for muscle injuries and disorders and sports related injuries and for improving exercise endurance, capacity and performance; medicines for preventing muscle injuries and disorders, sports related injuries ailments, cardiovascular ailments; medicines for treatment of heart related diseases and disorders; medicinal preparations for the mouth to be applied in the form of tablets; tablets for medicines, namely, drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations in the form of tablets for the prevention of muscle injuries and disorders, sports related injuries, improving exercise endurance, capacity and performance, increasing antioxidant levels, maintaining cholesterol at normal levels in healthy individuals and improving cardiovascular health; pharmaceutical tablets for muscle injuries and disorders, sports related injuries, improving exercise endurance, capacity and performance, improving exercise endurance, capacity and performance, increasing antioxidant levels, maintaining cholesterol at normal levels in healthy individuals and improving cardiovascular health; specialized tablets for the delivery of pharmaceuticals sold without the pharmaceutical ingredientACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 21, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 20, 2023FIMPFINAL DISPOSITION PROCESSED—
Feb 28, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 29, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 29, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 2, 2022GPNXNOTIFICATION PROCESSED BY IB—
Sep 20, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 13, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 7, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 31, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 31, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 24, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 20, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2022ALIEASSIGNED TO LIE—
Jun 30, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 1, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 1, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Mar 1, 2022CNSLSUSPENSION LETTER WRITTEN—
Feb 15, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 14, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 14, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2021RFNTREFUSAL PROCESSED BY IB—
Aug 19, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 19, 2021RFRRREFUSAL PROCESSED BY MPU—
Aug 6, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 5, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2021DOCKASSIGNED TO EXAMINER—
Apr 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance